EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia.
Llaó-Cid L, Roessner PM, Chapaprieta V, Öztürk S, Roider T, Bordas M, Izcue A, Colomer D, Dietrich S, Stilgenbauer S, Hanna B, Martín-Subero JI, Seiffert M.
Llaó-Cid L, et al. Among authors: seiffert m.
Leukemia. 2021 Nov;35(11):3152-3162. doi: 10.1038/s41375-021-01198-1. Epub 2021 Mar 17.
Leukemia. 2021.
PMID: 33731848
Free PMC article.